Empatab 25mg Tablet

What is Empatab?

Empatab is a brand of Empagliflozin manufactured by Incepta Pharmaceuticals Ltd. It belongs to the SGLT2 inhibitor class of oral antidiabetic medicines, used to improve blood glucose control in adults with type 2 diabetes mellitus by promoting glucose excretion through the kidneys.

Generic Name and Composition

Each tablet contains 25 mg of Empagliflozin.

Indications

• Type 2 diabetes mellitus, as monotherapy or combined with other antidiabetic agents (including metformin, insulin)
• Also used to reduce the risk of cardiovascular death in adults with type 2 diabetes and established cardiovascular disease, and in certain heart failure and chronic kidney disease patients, as determined by a physician

How It Works — Mechanism of Action

Empagliflozin inhibits the sodium-glucose co-transporter 2 (SGLT2) in the kidneys, reducing renal glucose reabsorption and increasing urinary glucose excretion. This lowers blood glucose levels independent of insulin secretion or action, and also provides modest weight loss and blood pressure reduction benefits.

Dosage and Administration

• Dosage is individualized by a physician; typically taken once daily in the morning, with or without food.
• Swallow the tablet whole with water.
• Maintain adequate hydration, as the medicine increases urination.
• Do not change the dose without consulting your physician.

Side Effects

Common: Urinary tract infections, genital fungal infections, increased urination, thirst.

Uncommon: Volume depletion/dehydration, hypotension, rash.

Rare: Diabetic ketoacidosis (sometimes with near-normal blood glucose), Fournier's gangrene (a rare but serious genital infection), severe urinary tract infections.

Drug Interactions

May enhance hypoglycemia: Insulin, sulfonylureas — dose adjustment of these agents may be needed when combined with empagliflozin.

May increase dehydration risk: Diuretics (e.g., furosemide, thiazides).

Other considerations: Inform your doctor of all medicines you are taking, including those affecting kidney function.

Contraindications

• Known hypersensitivity to empagliflozin or any excipient
• Severe renal impairment or dialysis-dependent kidney disease
• Type 1 diabetes mellitus or diabetic ketoacidosis

Pregnancy and Lactation

Empagliflozin is generally not recommended during pregnancy or breastfeeding. Insulin is typically preferred for glycemic control in these situations. Consult your physician for an appropriate alternative if pregnant or breastfeeding.

Precautions and Warnings

• Maintain good hydration, especially in hot weather, during illness, or with reduced food/fluid intake.
• Monitor for signs of urinary tract or genital infections and seek prompt treatment.
• Seek immediate medical attention for symptoms of ketoacidosis (nausea, vomiting, abdominal pain, unusual fatigue, difficulty breathing) even if blood glucose is not very high.
• Temporarily discontinue before major surgery or during acute serious illness, as advised by your physician.
• Use with caution in elderly patients and those at risk of volume depletion.

Overdose

Limited data exists on empagliflozin overdose. Management is supportive, focusing on monitoring for hypoglycemia, dehydration, and electrolyte imbalance, with appropriate clinical intervention as needed. Seek immediate medical attention in case of suspected overdose.

Storage Instructions

• Store below 30°C in a dry place, protected from light.
• Keep out of reach of children.
• Do not use after the expiry date printed on the pack.

Frequently Asked Questions

Q1: Why does Empatab increase urination?
Empatab works by causing the kidneys to remove excess glucose through urine, which naturally increases urine output. Staying well-hydrated helps offset this effect.

Q2: Can Empatab cause low blood sugar on its own?
Used alone, the risk of hypoglycemia is low, since its mechanism does not depend on insulin. Risk increases when combined with insulin or sulfonylureas.

Q3: Why am I more prone to genital or urinary infections on Empatab?
The increased glucose in urine can promote growth of yeast and bacteria. Good hygiene and prompt reporting of symptoms help manage this risk.

Q4: How is Empatab different from Dapaglip?
Both Empatab (empagliflozin) and Dapaglip (dapagliflozin) are SGLT2 inhibitors with a similar mechanism; they differ mainly in dosing and specific approved indications. Your physician will recommend the most suitable option.

Medical Disclaimer

This product is available by prescription only (Rx). The information provided is for educational purposes and does not replace professional medical advice. Always consult a registered physician before starting, stopping, or changing any diabetes therapy. DiabetesStore.com.bd is a licensed online pharmacy in Bangladesh.